Sign In
Buy OSUR
$3.95
-0.0500 (-1.25%)
At Close: Jun 03, 2026
Two Sigma Advisers LP Reduces Stock Position in OraSure Technologies, Inc. (NASDAQ:OSUR)
06:38am, Thursday, 25'th Jun 2020
Two Sigma Advisers LP reduced its holdings in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) by 21.8% during the first quarter, according to its most recent 13F filing with the Securities and Exch
Greater Than AIDS, With Support From Walgreens and OraSure Technologies, to Provide 10,000 Free In-Home HIV Tests to Community Partners
12:00am, Thursday, 25'th Jun 2020
Greater Than AIDS will provide 10,000 free in-home HIV tests to community partners.
Hedge Funds Warming Up To OraSure Technologies, Inc. (OSUR)
04:52pm, Tuesday, 23'rd Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
OraSure’s DNA Genotek Subsidiary Unveils First In-Home Self-Collection Device for Metabolomics
11:00am, Wednesday, 17'th Jun 2020
OraSure Technologies, Inc. (OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services is introducing the first and only commerci
Metabolon, Inc. and DNA Genotek Collaborate on First Ambient-Temperature Microbiome Sampling Solution for Metabolomics
11:00am, Wednesday, 17'th Jun 2020
Metabolon, Inc., the global leader in metabolomics, and DNA Genotek, a subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), have collaborated to bring OMNImet™·GUT, the first device for in-home
OraSure Technologies Reports Received $629K In BARDA Funding For Coronavirus Antibody ELISA Using Oral Fluid Samples
12:10pm, Wednesday, 10'th Jun 2020OraSure Technologies Receives BARDA Funding for Coronavirus Antibody ELISA Using Oral Fluid Samples
12:00pm, Wednesday, 10'th Jun 2020
OraSure Technologies, Inc. (OSUR), a leader in point-of-care diagnostic tests, specimen collection devices and microbiome laboratory and analytical services, today announced it has been awarded a $629
OraSure's Oragene•Dx Included In EUA Allowing At-Home Saliva Collection For Use With Phosphorus SARS-CoV-2 Test
12:18pm, Monday, 08'th Jun 2020OraSure's Oragene®•Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test
12:10pm, Monday, 08'th Jun 2020OraSure’s Oragene®•Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test
12:00pm, Monday, 08'th Jun 2020
OTTAWA, June 08, 2020 -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and.
OraSure Technologies Yesterday Announces Exercise of Option to Purchase Additional Shares of Common Stock
12:39pm, Thursday, 04'th Jun 2020OraSure Technologies, Inc. Announces Exercise of Option to Purchase Additional Shares of Common Stock
12:50am, Thursday, 04'th Jun 2020
In total, 9,200,000 shares of common stock of the Company are being sold in the offering. With the exercise by the underwriters of their option to purchase such additional shares, after the underwrit
